World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
89
Citations
27622
World Ranking
12741
National Ranking
175

Overview

Bernd C. Kieseier is affiliated with Novartis (Switzerland) and has a research focus predominantly in the field of Medicine, with specialization across several related subfields. Their work notably involves Pathology and Forensic Medicine, Neurology, Hematology, Genetics, and Radiology, Nuclear Medicine and Imaging.

The scientist has an extensive publication record with significant contributions to Multiple Sclerosis Research Studies, which form the core of their work. Other research topics include Chronic Lymphocytic Leukemia Research, Peripheral Neuropathies and Disorders, Chronic Myeloid Leukemia Treatments, Monoclonal and Polyclonal Antibodies Research, Rheumatoid Arthritis Research and Therapies, and Acute Lymphoblastic Leukemia research.

Frequent collaborators in their research efforts include:

  • Xavier Montalbán
  • Roman Willi
  • Heinz Wiendl
  • Ludwig Kappos
  • Dieter A. Häring

Kieseier's recent papers reflect an emphasis on multiple sclerosis and associated neurological conditions. Notable publications include:

  • How patients with multiple sclerosis acquire disability, 2022, Brain
  • Blood neurofilament light levels segregate treatment effects in multiple sclerosis, 2020, Neurology
  • Harnessing Real-World Data to Inform Decision-Making: Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS), 2020, Frontiers in Neurology
  • Efficacy and safety of ofatumumab in recently diagnosed, treatment-naive patients with multiple sclerosis: Results from ASCLEPIOS I and II, 2022, Multiple Sclerosis Journal
  • Safety experience with continued exposure to ofatumumab in patients with relapsing forms of multiple sclerosis for up to 3.5 years, 2022, Multiple Sclerosis Journal

The publication venues where the scientist frequently contributes include Neurology, Multiple Sclerosis Journal, Multiple Sclerosis and Related Disorders, Frontiers in Neurology, and Brain. The largest number of publications are found in Neurology and Multiple Sclerosis Journal.

With over 110 publications recorded in Medicine, Kieseier's scholarly output reflects a multidisciplinary approach integrating pathology, neurology, hematology, genetics, and imaging related to chronic neurological and hematological diseases.

Best Publications

  • Defining the clinical course of multiple sclerosis: The 2013 revisions

    Fred D. Lublin;Stephen C. Reingold;Jeffrey A. Cohen;Gary R. Cutter

  • Chronic Inflammatory Demyelinating Polyneuropathy

    Hubertus Köller;Bernd C. Kieseier;Sebastian Jander;Hans-Peter Hartung

  • Acute disseminated encephalomyelitis: an update.

    Til Menge;Bernhard Hemmer;Stefan Nessler;Heinz Wiendl

  • Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study

    Peter A Calabresi;Bernd C Kieseier;Douglas L Arnold;Laura J Balcer

  • The Global Adherence Project (GAP): a multicenter observational study on adherence to disease‐modifying therapies in patients with relapsing‐remitting multiple sclerosis

    V. Devonshire;Y. Lapierre;R. Macdonell;C. Ramo-Tello

  • The role of macrophages in immune-mediated damage to the peripheral nervous system.

    Reinhard Kiefer;Bernd C. Kieseier;Guido Stoll;Hans-Peter Hartung

  • Interferon-β enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis

    Bettina Schreiner;Meike Mitsdoerffer;Bernd C. Kieseier;Lieping Chen

  • Clinical relevance of brain volume measures in multiple sclerosis.

    Nicola De Stefano;Laura Airas;Nikolaos Grigoriadis;Heinrich P. Mattle

  • Immunopathogenesis and immunotherapy of multiple sclerosis.

    Bernhard Hemmer;Stefan Nessler;Dun Zhou;Bernd Kieseier

  • The mechanism of action of interferon-β in relapsing multiple sclerosis.

    Bernd C. Kieseier

  • Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study

    J. Kuhle;G. Disanto;R. Dobson;R. Adiutori

  • Assessing walking disability in multiple sclerosis

    Bernd C. Kieseier;Carlo Pozzilli

  • Regional variation of Guillain-Barre syndrome

    Alex Y. Doets;Christine Verboon;Bianca Van Den Berg;Thomas Harbo

  • Statins as immunomodulators Comparison with interferon-β1b in MS

    O. Neuhaus;S. Strasser-Fuchs;F. Fazekas;B.C. Kieseier

  • Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumab.

    Per Soelberg Sørensen;Antonio Bertolotto;Gilles Edan;Gavin Giovannoni

  • Long-term Therapy With Interleukin 6 Receptor Blockade in Highly Active Neuromyelitis Optica Spectrum Disorder.

    Marius Ringelstein;Ilya Ayzenberg;Jens Harmel;Ann-Sophie Lauenstein

  • The monoclonal anti-VLA-4 antibody natalizumab mobilizes CD34 hematopoietic progenitor cells in humans

    Fabian Zohren;Diamandis Toutzaris;Viola Klärner;Hans-Peter Hartung

  • Advances in understanding and treatment of immune-mediated disorders of the peripheral nervous system.

    Bernd C. Kieseier;Reinhard Kiefer;Ralf Gold;Bernhard Hemmer

  • Immunobiology of muscle: advances in understanding an immunological microenvironment

    Heinz Wiendl;Reinhard Hohlfeld;Bernd C. Kieseier

  • Matrix metalloproteinases in inflammatory demyelination Targets for treatment

    Bernd C. Kieseier;Thomas Seifert;Gavin Giovannoni;Hans-Peter Hartung

Frequent Co-Authors

Hans-Peter Hartung
Hans-Peter Hartung Heinrich Heine University Düsseldorf
Heinz Wiendl
Heinz Wiendl University of Münster
Olaf Stüve
Olaf Stüve The University of Texas Southwestern Medical Center
Bernhard Hemmer
Bernhard Hemmer Technical University of Munich
Ralf Gold
Ralf Gold Ruhr University Bochum
Douglas L. Arnold
Douglas L. Arnold Montreal Neurological Institute and Hospital
Christoph Kleinschnitz
Christoph Kleinschnitz University of Duisburg-Essen
Orhan Aktas
Orhan Aktas Heinrich Heine University Düsseldorf
Peter A. Calabresi
Peter A. Calabresi Johns Hopkins University School of Medicine
Xavier Montalban
Xavier Montalban Autonomous University of Barcelona

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re exploring medicine as a career, there are several related online degree options and career pathways worth considering. These programs can provide valuable foundations for various roles in the healthcare industry or serve as stepping stones towards advanced medical education.

An online bachelor's in health information management focuses on the management of patient data, electronic health records, and healthcare compliance. This field is essential for supporting healthcare operations and security.

For those interested in administrative roles, you might wonder how much is medical billing and coding school. These programs are generally affordable and can lead to roles that ensure accurate billing, insurance coding, and reimbursement for healthcare providers.

Nursing remains a popular field, and prospective students often ask most affordable online nurse practitioner programs to compare cost-effective ways to become advanced practice nurses. There are also options for traditional pathways—check how much is online nursing school for insights on tuition and program choices.

Exploring these alternatives can open up fulfilling careers in healthcare without the extensive commitment required for a traditional M.D.

Best Scientists Citing Bernd C. Kieseier

Trending Scientists